dCas9 metabolic enzyme fusions modulate global and locus specific gene expression
Kellen Biesbrock, Spencer A. Haws, Harshini Cormaty, Rupa Sridharan, John M. Denu
This study introduces CRISPRm, a dCas9-metabolic enzyme fusion platform, to investigate how nuclear metabolic perturbations affect gene expression and chromatin states in HEK293T cells.
bioRxiv · May 10, 2026 · PreprintBiochemistry